 |
 |
 |
 |
 |
 |
 |
 |
Real-world coronary patient registries New observational studies using the AngioJet system to treat heart attack patients were published as a supplement to the July 2006 issue of The Journal of Invasive Cardiology. The supplement details "real-world" results from five patient registries, including one from the Thoraxcentre in Rotterdam, which showed the effectiveness and safety of using AngioJet to treat heart attack patients with large thrombus. |
Premiering in 1997, Possis’ AngioJet remains the medical world’s leading mechanical thrombectomy system. The AngioJet system is comprised of three components: a drive unit, a pump set and a family of catheters, each catheter uniquely designed for optimal performance in different vascular territories. Widely recognized by physicians as quick, safe and effective, our AngioJet technology is protected by more than 34 patents, with 59 more pending. With our new Ultra Console, we’re introducing the next-generation AngioJet system. Designed to drive the disposable pump and monitor flow and volume of the pressurized saline solution that is delivered to the catheter tip, the Ultra Console builds on our existing core AngioJet technology and provides significantly easier set-up, and more flexibility for future catheter designs. Now pending approval at FDA, the Ultra Console will help generate growth for Possis’ AngioJet business.
|